Targeting

BET is conducting research and validation studies utilizing its key bioactives and their compounds targeting:

 

Ø  Replacing synthetic chemicals for food shelf life stability.

Ø  Antibiotic replacement and functionalities in veterinary and medical treatments.

Ø  Nutraceutical applications wherein bioavailability and bio absorption of essential minerals play a dominant role in health and disease pathophysiology.

Ø  Natural immunoglobulin agglomerations as carriers and effectors for animal and human health.

Ø  Specific formulations and compound mixtures for treatment for both bacterial and viral based sepsis.